170374 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Muscle proteins, e.g. myosin, actin, protein
CHEMILUMINESCENCE-BASED DUAL FLOW RAPID DIAGNOSTIC TESTING PLATFORM AND METHODS OF USE
#2ELECTROCHEMICAL REGENERATION OF IMMUNOSENSORS
#3TREATMENT AND METHOD FOR PREDICTING DISEASE INCIDENCE, PROGRESSION, AND PROGNOSIS OF GLIOMA
#4NEUTRALIZATION ANTIBODY ASSAY METHOD
#5APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS
#6DETERMINING AN AMOUNT OF ANALYTE IN PLASMA BASED ON A MEASUREMENT OF AN AMOUNT OF ANALYTE IN A WHOLE-BLOOD SAMPLE
#7CHROMOGENIC MULTIPLEXING METHODS AND SYSTEMS FOR IDENTIFYING A CANCER OF UNKNOWN PRIMARY ORIGIN
#8METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#9ANTIBODIES AND THERAPEUTIC USES THEREOF
#10METHODS OF TREATING EPILEPSY
#11Nanotechnology-enabled, printable biosensors for diseases detection and method of producing thereof
#12METHODS FOR PREDICTING THE USEFULNESS OF PROTEINS OR PROTEIN FRAGMENTS FOR IMMUNOTHERAPY
#13CMYBPC MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION
#14METHOD FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS AND THE USE OF STEROIDS/PROTEINS FOR PREDICTING THE POSTOPERATIVE RISK OF BRAIN-INJURED PATIENTS
#15ASSAY FOR LONG FORMS OF CARDIAC TROPONIN T
#16ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#17PHOSPHOPEPTIDE/PHOSPHOPROTEIN SIGNATURE PREDICTING BASAL-LIKE BREAST CANCER RECURRENCE
#18METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS
#19KIDNEY-ON-A-CHIP COMPRISING RENAL TUBULE CULTURE PART AND INTERSTITIUM CULTURE PART
#20METHODS AND COMPOSITIONS COMPRISING ACTIN BINDING PROTEINS
#21DIAGNOSTIC ASSAY REAGENTS COMPRISING BLOCK CO-POLYMERS
#22PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY
#23METHOD FOR MEASURING AGGREGATING PROTEINS, METHOD FOR VISUALIZING AGGREGATION, AND KIT USED THEREFOR
#24METHOD OF PROGNOSIS
#25TARGET ANALYTE DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION
#26ANTIBODY AND DNA OLIGO CONJUGATES AND THEIR APPLICATION IN ELISA-PCR TESTS
#27BIOSENSOR FOR DETECTING STRUCTURAL CHANGES IN HUMAN CARDIAC MUSCLE PROTEIN
#28DEVICE AND METHOD FOR MEASURING THE LEVEL OF BIOMARKERS AND PATHOGENS IN SUBSTANCES
#29METHODS FOR MEASURING DYSTROPHIN IN TISSUE SAMPLES
#30Immunoassay controls and the use thereof
#31METHOD FOR PROGNOSIS
#32MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS
#33METHOD AND KIT OF MEASURING CONCENTRATION OF ANALYTE
#34NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO
#35METASTATIC BIOMARKER
#36PREVENTION AND INTERVENTION OF INFARCT EXPANSION FOLLOWING HEMORRHAGIC INFARCTIONS
#37TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#38AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED BY NANOTECHNOLOGY AND PROTEOMICS
#39IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#40Gene Expression Inflammatory Age and Its Uses
#41METHOD FOR ACQUIRING INFORMATION ON SPINAL MUSCULAR ATROPHY
#42Methods of treating epilepsy
#43NOVEL ANTI-TROPONINT ANTIBODIES
#44SYSTEMS AND METHODS FOR IDENTIFYING SUBTYPE, PROGNOSIS, AND MONITORING OF BREAST CANCER
#45Detection and Quantification of Molecular Species
#46Immunoassay controls and the use thereof
#47Antibody against human cardiac troponin i and use thereof
#48Antibody against human cardiac troponin I and use thereof
#49Antibodies and therapeutic uses thereof
#50SYNTHETIC BI-EPITOPE COMPOUND
#51Use of Biomarkers in the Assessment of the Early Transition from Arterial Hypertension to Heart Failure
#52BIOMARKERS FOR RADIATION TREATMENT
#53Cofilin phosphorylation for quantifying CD4 T cell damage and predict CD4 T cell recovery from anti-retroviral therapy
#54Compositions and methods relating to a C-terminal peptide of troponin i with activity as a myofilament CA2+ desensitizer
#55MULTIVALENT MONO- OR BISPECIFIC RECOMBINANT ANTIBODIES FOR ANALYTIC PURPOSE
#56Anti-troponin T antibodies
#57Methods to identify modulators of actin-binding proteins
#58BIOMARKERS FOR RISK PREDICTION OF MORTALITY
#59Treating and preventing diseases by modulating cell mechanics
#60PREDICTIVE BIOMARKERS FOR TREATMENT OF EYE DISEASES
#61Nucleic acids encoding anti-HcTNT-N69 antibodies
#62Biosensors and methods for detection of lysophosphatidic acid for signaling of ovarian cancer
#63METHOD OF PROGNOSIS
#64Method of treating acute coronary syndrome
#65GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients
#66Assays for detecting analytes in samples and kits and compositions related thereto
#67METHOD FOR DIAGNOSIS OF UNSTABLE ATHEROSCLEROTIC PLAQUES
#68Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
#69PROTEOLYTIC DIGESTION OF CARDIAC TROPONIN I
#70System and method for detection of trauma
#71Method for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy
#72COMPOSITIONS AND METHODS FOR CONTROLLING NATURAL KILLER CELL ACTIVATION AND FUNCTION
#73Immunoassay controls and the use thereof
#74Methods for detecting cardiac damage
#75METHOD AND KIT FOR DETERMINING PROGNOSIS, REMOTE RECURRENCE RISK AND INVASION OF GLIOMA, AND PHARMACEUTICAL COMPOSITION FOR TREATING GLIOMA
#76Personalized healthcare P4 cardiac health and wellness monitoring system and method utilizing TMAO and troponin
#77Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
#78CIRCULATING ESM-1 (ENDOCAN) IN THE ASSESSMENT OF ATRIAL FIBRILLATION AND/OR STROKE
#79ONE STEP CARDIAC TEST DEVICE
#80Treating and preventing diseases by modulating cell mechanics
#81Methods of treating intestinal fibrosis using SMAD7 inhibition
#82TROPONIN I AND SOLUBLE UROKINASE RECEPTOR DETECTION FOR DETERMINING THE RISK OF CARDIOVASCULAR DISEASE
#83Inflammatory Disease Treatment Composition Including Anti-Myosin Regulatory Light-Chain Polypeptide Antibody
#84Methods and compositions relating to anti-HcTnT-N69 antibody for detection of cardiac disorders
#85Peptides derived from myosin 19 and methods of use thereof
#86Systems, Methods and Computer Readable Storage Media for Analyzing a Sample
#87Cartridge for diagnostic testing
#88Biomarkers for radiation treatment
#89DETECTION OF ACUTE MYOCARDIAL INFARCTION
#90REAGENT AND METHOD FOR MEASURING CARDIAC TROPONIN I
#91Multiple hybrid immunoassay
#92Method of Determining Risk of an Adverse Cardiac Event
#93Methods and compositions for the diagnosis of ovarian cancer
#94METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS
#95Biomarkers to improve prediction of heart failure risk
#96Assessing whether a subject shall be subjected to imaging based diagnostic
#97Troponin and BNP based diagnosis of risk patients and cause of stroke
#98Cardiovascular risk event prediction and uses thereof
#99BIOMARKER FOR CARDIAC DISORDERS
#100BIOSENSORS AND METHODS FOR DETECTION OF LYSOPHOSPHATIDIC ACID FOR SIGNALING OF OVARIAN CANCER
#101CELL ANALYSIS USING DYNAMIC BIOPHYSICAL METHODS
#102Biomarkers in Cancer, Methods, and Systems Related Thereto
#103Methods for diagnosing and reducing incidences of cardiac allograft rejection
#104BIOPLASMONIC DETECTION OF BIOMARKERS IN BODY FLUIDS USING PEPTIDE RECOGNITION ELEMENTS
#105Methods for detecting cardiac damage
#106MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS
#107METHODS FOR QUANTITATIVE ASSESSMENT OF MUSCLE FIBERS IN MUSCULAR DYSTROPHY
#108Proteolytic digestion of cardiac troponin I
#109Method for identifying a compound useful with myosin regulatory light chain polypeptide antibody for treatment of an inflammatory disease
#110Decision tree based systems and methods for estimating the risk of acute coronary syndrome
#111Synthetic bi-epitope compound
#112Methods for assessing differential risk for developing heart failure
#113Kit for rapidly testing myocardial infarction and a preparation method and an application thereof
#114Cartridge for diagnostic testing
#115REACTION METHOD, DETECTION METHOD, AND DETECTION DEVICE
#116Assays for detecting analytes in samples and kits and compositions related thereto
#117Methods and compositions for wound treatment
#118TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#119Hybridoma cell lines (My-C-cC0C2-259-1 A4) and use thereof for producing a monoclonal antibody against human cardiac myosin binding protein C (C-protein, MYBPC3, cMyBP-C or My-C)
#120TROPONIN AND BNP BASED DIAGNOSIS OF RISK PATIENTS AND CAUSE OF STROKE
#121Method of Detection of Summed Cardiac Troponins for Cardiovascular Risk Stratification
#122Uses of GLI1 in detecting tissue fibrosis
#123Methods and compositions for expressing functional class XIV myosin
#124Biomarker for cardiac disorders
#125SENSORS HAVING INTERNAL CALIBRATION OR POSITIVE CONTROLS
#126BIOMARKERS TO IMPROVE PREDICTION OF HEART FAILURE RISK
#127Methods for detecting cardiac damage
#128Methods to detect myocardial injury and uses thereof
#129Cell analysis using dynamic biophysical methods
#130Methods for treating or reducing the risk of arthritis in a subject by administering gelsolin
#131Biomarkers for Epithelial Cancer Diagnosis and Treatment
#132Peptides derived from myosin 19 and methods of use thereof
#133USE OF ALPHA-CRYSTALLIN B (CRYAB) IN THE ASSESSMENT OF HEART FAILURE
#134Multiple hybrid immunoassay
#135Fluorescence immunoassay sensor chip and fluorescence immunoassay method
#136GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#137Inflammatory disease treatment composition including anti-myosin regulatory light-chain polypeptide antibody
#138MARKER FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION, AND METHOD FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION BY USING SAME
#139Simplified extraction methods for the rapid determination of species content of adipose tissue based on the detection of TNI in immunoassays
#140Biomarkers for radiation treatment
#141Devices, methods, and kits for detecting an analyte in a sample
#142Podocyte cultures and uses thereof
#143ASSESSING SUSCEPTIBILITY TO CARDIAC INTERVENTION, SUSCEPTIBILITY TO THERAPY FOR HEART FAILURE, RISK OF MORTALITY OR FURTHER CARDIOVASCULAR EVENTS, AND RISK OF SUBSEQUENT PULMONARY EMBOLISM IN RELEVANT PATIENTS BASED ON DETERMINATIONS OF GDF-15, NATRIURETIC PEPTIDE, CARDIAC TROPONIN OR COMBINATIONS THEREOF
#144SYSTEMS, METHODS AND COMPUTER READABLE STORAGE MEDIA FOR ANALYZING A SAMPLE
#145BIOMARKERS IN CANCER, METHODS, AND SYSTEMS RELATED THERETO
#146Methods and compositions for expressing functional class XIV myosin
#147Method for aiding diagnosis of Alzheimer's disease
#148Method for diagnosing muscular dystrophy
#149TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#150ANKRD26 AS A MARKER FOR DIAGNOSIS OF THROMBOCYTOPENIAS
#151Green-to-red photo-convertible fluorescent calcium indicator
#152In vitro assay for predicting renal proximal tubular cell toxicity
#153Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment
#154IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING
#155METHOD AND AGENTS TO QUANTIFY PROTEINS FROM TISSUES
#156METHODS AND COMPOSITIONS RELATED TO THE SMCHD1 GENE
#157MATERIALS AND METHODS FOR DIAGNOSING AND TREATING SHELLFISH ALLERGY
#158PEPTIDE AND ANTIBODY LIBRARIES AND USES THEREOF
#159COMPOSITIONS AND METHODS FOR DIAGNOSIS AND THERAPY OF DISORDERS RELATED TO ALTERATIONS OF MYH9
#160Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
#161ASSAY LABEL
#162Methods for detecting cardiac damage
#163MULTILEVEL ANALYTE ASSAY
#164In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein
#165Multiple hybrid immunoassay
#166Cartridge for diagnostic testing
#167Methods and compositions for the diagnosis of ovarian cancer
#168Monoclonal antibodies against alpha-actinin-4 antigens, and uses therefor
#169Methods useful in studying or modulating skin or hair pigmentation, plant extracts for use in compositions and cosmetic care method
#170Method for measuring cardiac troponin
#171Highly sensitive biomarker panels
#172Devices and methods for controlling actin filaments growth and organization using micropatterned nucleation sites
#173HIGHLY SENSITIVE METHOD FOR ASSAYING TROPONIN I
#174TROPONIN BASED RULE-IN AND RULE-OUT ALGORITHM OF MYOCARDIAL INFARCTION
#175Marker for detecting gastric cancer and method for detecting gastric cancer
#176DNA aptamer specifically binding to human cardiac troponin I
#177METHODS AND ASSAYS FOR RISK PREDICTION, DIAGNOSIS, AND ANALYSIS OF MYOCARDIAL INFARCTION, HEART FAILURE AND REDUCED CARDIAC FUNCTION
#178GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#179Myosin-IIA S1943 phosphorylation as a marker of tumor invasion
#180METHOD, KIT OR DIAGNOSTIC FOR THE DETECTION OF REAGENTS WHICH INDUCE ALTERED CONTRACTILITY
#181MATERIALS AND METHODS FOR DIAGNOSING AND TREATING SHELLFISH ALLERGY
#182Preparation of phalloidin and its derivatives
#183Use of gelsolin to diagnose and treat inflammatory diseases
#184Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm
#185MARKER PANEL FOR LEFT VENTRICULAR HYPERTROPHY
#186Methods and compositions for wound treatment
#187Methods and compositions of nucleic acid ligands for detection of clinical analytes related to human health
#188Post-translation modified cardiac troponin T as a biomarker of a risk for heart failure
#189Amelioration of heterophile antibody immunosensor interference
#190Method for the in vitro diagnosis of stroke
#191BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS
#192ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR
#193Methods useful in studying or modulating skin or hair pigmentation, plant extracts for use in compositions and cosmetic care method
#194IMMUNOASSAYS FOR AUTOANTIBODIES IN CARDIOVASCULAR DISEASES
#195GENETICALLY ENCODED CALCIUM SENSORS COMPRISING THE C-TERMINAL LOBE OF TROPONIN C AND A FLUORESCENCE TAG
#196NOVEL ASSAYS FOR DETECTING ANALYTES IN SAMPLES AND KITS AND COMPOSITIONS RELATED THERETO
#197D-dimer, troponin, and NT-proBNP for pulmonary embolism
#198Assay for diagnosis of cardiac myocyte damage
#199Microfluidic control chip and method of detecting protein using the same
#200Assay for cardiac troponin-T (cTnT)
#201Screening for compounds having immunosuppressant activity by testing impact on leukocyte-specific calcium fluxes
#202USING CARDIAC TROPONIN FOR MONITORING ANTI-ANGIOGENESIS THERAPY
#203Identification of subjects being susceptible to anti-angiogenesis therapy
#204MULTIMARKER PANEL FOR MONITORING PATIENTS WITH AND WITHOUT OVERT HEART FAILURE
#205Methods for detecting cardiac damage
#206LATERAL-FLOW IMMUNO-CHROMATOGRAPHIC ASSAY DEVICES
#207Detection of cardiac markers on a droplet actuator
#208Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereof
#209IDENTIFYING SUSCEPTIBILITY OF A SUBJECT TO CARDIAC THERAPY BASED ON DETERMINATION OF A CARDIAC TROPONIN, SCD40L, AND C-REACTIVE PROTEIN
#210L-FABP, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy
#211Methods and kits for separation and detection of proteins in biological samples
#212Detection of endometrial secretion markers for assessment of endometriosis
#213Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#214Highly sensitive biomarker panels
#215Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility
#216METHODS AND KITS FOR DIAGNOSIS AND TREATMENT OF CELL-CELL JUNCTION RELATED DISORDERS
#217DIFFERENTIATION OF CAUSES OF RIGHT HEART FAILURE
#218Amelioration of heterophile antibody immunosensor interference
#219Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
#220Method for prediction of postoperative prognosis and diagnosis kit
#221Screening Assays for Antagonists and Analyses of Cardiac Hypertrophy
#222Producing a mammalian pluripotent cell population from mammalian blastomere-like stem cells (BLSCs)
#223Making a prognosis in cases of cardiac disease using a combination of markers
#224SINGLE MOLECULE ASSAYS
#225Highly sensitive method for detecting protein in food
#226Diagnostic means and methods using troponin T and NT-proBNP
#227Methods for Reducing Sample Size of Clinical Trials
#228SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS
#229Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)
#230Methods for early diagnosis of acute coronary syndrome
#231Bicyclic Compounds and Their Use
#232METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE DETECTION OF MOLECULES
#233Differentiation of acute and chronic myocardial necrosis in symptomatic patients
#234Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
#235Plus end-directed microtubule motor required for chromosome congression
#236Biological markers predictive of anti-cancer response to kinase inhibitors
#237Methods of screening for modulators of h2-calponin activity
#238Immunoassay
#239Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia
#240Cardiac troponin as an indicator of coronary artery disease
#241N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease
#242Use of Modulators of a Novel Form of Muscle Selective Calcineurin Interacting Protein (Mcip-1-38) as a Treatment for Cardiovascular Diseases
#243Test System for the Discovery of Substances for the Promotion of Neuraxonal Growth
#244Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
#245Reduction of platelet interference in plasma assay samples
#246Methods for improving the recovery of troponin I and T in membranes, filters and vessels
#247Measuring troponin antibodies to assess cardiovascular risk
#248Flj10607 as modifier of the axin pathway and methods of use
#249In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto
#250Method for analyzing tumor aggressivity comprising measurement of polymerized actin
#251Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor
#252Methods and kits for separation and detection of proteins in biological samples
#253Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain
#254Plus end-directed microtubule motor required for chromosome congression
#255Stabilized liquid reference solutions
#256Cell surface tropomyosin as a target of angiogenesis inhibition
#257Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
#258Methods for assessing muscle protein wasting and therapeutics therefor
#259Methods and compositions for use in diagnosing and characterizing chronic immune disease
#260Cellular analysis
#261Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis
#262Methods for quantitative assessment of muscle fibers in muscular dystrophy